Bristol-Myers Squibb Company (BMY) valuation · P/E 13, rev $48.19B
Bristol-Myers Squibb Company (BMY) P/E 13, rev $48.19B.
| Metric | Value |
|---|---|
| P/E | 13 |
| Market cap | $95.36B |
| Revenue | $48.19B |
| P/S | 2.0 |
| Dividend yield | 5.36% |
BMY valuation FAQ
What is BMY's P/E ratio?
Bristol-Myers Squibb Company (BMY) trailing P/E is 13 on the latest cached fundamentals snapshot.
What is BMY's market cap?
Bristol-Myers Squibb Company (BMY) market cap is $95.36B on the latest cached fundamentals snapshot.
What is BMY's latest revenue?
Latest cached Bristol-Myers Squibb Company (BMY) revenue was $48.19B. Statements: https://lician.com/financials/bmy
What is BMY's price-to-sales ratio?
Bristol-Myers Squibb Company (BMY) price-to-sales (P/S) is 2.0, cached market cap $95.36B divided by revenue $48.19B.
What is BMY's dividend yield?
Bristol-Myers Squibb Company (BMY) dividend yield is 5.36% on the latest cached fundamentals snapshot.
How many BMY valuation scalars are listed on this page?
This page lists 5 cached valuation scalars for Bristol-Myers Squibb Company (BMY): P/E, Market cap, Revenue, P/S, and Dividend yield.
Where is BMY valuation listed?
Cached valuation multiples for Bristol-Myers Squibb Company (BMY) are listed at https://lician.com/valuation/bmy.
Not investment advice. Cached rows, not a live tape.